Biotechnology ecosystem is well known by our studio as we are dedicated to the creation and development of disruptive biotech startups, using an interdisciplinary body and an inventive, yet highly effective, infrastructure.
We are part of
We have already supported more than 20 biotech companies ...
... which had led to the creation of more than 300 jobs.
We have managed to fundraise more than 40M€ in total ...
... to reach an enterprise value of more than 200M€.
Biotechnology ecosystem is well known by our studio as we are dedicated to the creation and development of disruptive biotech startups, using an interdisciplinary body and an inventive, yet highly effective, infrastructure.
We build synergies among our network, allowing for closer collaboration between co-founders of the startup, and make the funds available.
We provide advices and solutions at the financial, strategic and operational level to support high potential startups go through tipping points at each stage of their launch.
With our experimented Shared Services in biotech industry, we mitigate non-core risks and therefore assure our partners a sustainable growth.
With our knowledge of the ecosystem, we identify synergies among our network to induce a closer collaboration between our partners in order to create, finance and coordinate alliances.
As a well-versed professional, I built my extensive experience in Consulting, Strategy & Operations within Deloitte and as a Chief Financial Officer for various biotechnology startups, including MaSTherCell, OncoDNA, Univercells, Digital Orthopaedics and Artelis.
Guillaume de VironCo-founder![]()